Sterile endophthalmitis after intravitreal ocriplasmin injection: report of a single case

Retinal Cases & Brief Reports
Ian C Han, Adrienne W Scott

Abstract

To report a case of presumed sterile endophthalmitis after intravitreal ocriplasmin injection. Observational case report. Review of clinical examination, ocular imaging, and published literature. A 67-year-old woman with early cataracts presented with decreased vision in the left eye related to vitreomacular adhesion. She was treated with intravitreal ocriplasmin injection and developed a severe anterior chamber inflammatory reaction in less than 24 hours after the injection. Inflammation responded completely to topical steroids alone, without topical or intravitreal antibiotics. Patients treated with intravitreal ocriplasmin may develop an acute inflammatory reaction, which can be severe.

References

Jun 28, 2011·Ophthalmology·Chirag P ShahUNKNOWN Post-Injection Endophthalmitis (PIE) Study Team
May 9, 2012·Journal of Leukocyte Biology·Tatiana SyrovetsThomas Simmet

❮ Previous
Next ❯

Citations

May 4, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Irini ChatziralliPanagiotis Theodossiadis
Nov 14, 2018·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A ChronopoulosL-O Hattenbach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Technology Evaluation Center Assessment Program. Executive Summary
Blue Cross and Blue Shield Association
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye
Darius M MoshfeghiWilliam F Mieler
© 2021 Meta ULC. All rights reserved